| Product Code: ETC6657504 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Genomics Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Genomics Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Genomics Market - Industry Life Cycle |
3.4 Canada Genomics Market - Porter's Five Forces |
3.5 Canada Genomics Market Revenues & Volume Share, By Application & Technology, 2021 & 2031F |
3.6 Canada Genomics Market Revenues & Volume Share, By Technology Outlook, 2021 & 2031F |
3.7 Canada Genomics Market Revenues & Volume Share, By Deliverables, 2021 & 2031F |
3.8 Canada Genomics Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Canada Genomics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government funding and initiatives for genomics research in Canada |
4.2.2 Rising demand for personalized medicine and precision healthcare |
4.2.3 Growing adoption of genomic technologies in agriculture and livestock breeding |
4.3 Market Restraints |
4.3.1 High costs associated with genomics research and testing |
4.3.2 Limited availability of skilled professionals in the genomics field |
4.3.3 Stringent regulatory requirements and ethical concerns surrounding genomic data usage |
5 Canada Genomics Market Trends |
6 Canada Genomics Market, By Types |
6.1 Canada Genomics Market, By Application & Technology |
6.1.1 Overview and Analysis |
6.1.2 Canada Genomics Market Revenues & Volume, By Application & Technology, 2021- 2031F |
6.1.3 Canada Genomics Market Revenues & Volume, By Functional Genomics, 2021- 2031F |
6.1.4 Canada Genomics Market Revenues & Volume, By Epigenomics, 2021- 2031F |
6.1.5 Canada Genomics Market Revenues & Volume, By Pathway Analysis, 2021- 2031F |
6.1.6 Canada Genomics Market Revenues & Volume, By Biomarker Discovery, 2021- 2031F |
6.1.7 Canada Genomics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Canada Genomics Market, By Technology Outlook |
6.2.1 Overview and Analysis |
6.2.2 Canada Genomics Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.2.3 Canada Genomics Market Revenues & Volume, By PCR, 2021- 2031F |
6.2.4 Canada Genomics Market Revenues & Volume, By Flow Cytometry, 2021- 2031F |
6.2.5 Canada Genomics Market Revenues & Volume, By Microarrays, 2021- 2031F |
6.2.6 Canada Genomics Market Revenues & Volume, By Other technologies, 2021- 2031F |
6.3 Canada Genomics Market, By Deliverables |
6.3.1 Overview and Analysis |
6.3.2 Canada Genomics Market Revenues & Volume, By Products, 2021- 2031F |
6.3.3 Canada Genomics Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Canada Genomics Market, By End-use |
6.4.1 Overview and Analysis |
6.4.2 Canada Genomics Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.4.3 Canada Genomics Market Revenues & Volume, By Academic & Government Institutes, 2021- 2031F |
6.4.4 Canada Genomics Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.4.5 Canada Genomics Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.6 Canada Genomics Market Revenues & Volume, By Other End Users, 2021- 2031F |
7 Canada Genomics Market Import-Export Trade Statistics |
7.1 Canada Genomics Market Export to Major Countries |
7.2 Canada Genomics Market Imports from Major Countries |
8 Canada Genomics Market Key Performance Indicators |
8.1 Number of research grants awarded for genomics projects in Canada |
8.2 Adoption rate of genomic testing in healthcare institutions and research facilities |
8.3 Percentage of increase in genomic data sharing collaborations between academia and industry |
9 Canada Genomics Market - Opportunity Assessment |
9.1 Canada Genomics Market Opportunity Assessment, By Application & Technology, 2021 & 2031F |
9.2 Canada Genomics Market Opportunity Assessment, By Technology Outlook, 2021 & 2031F |
9.3 Canada Genomics Market Opportunity Assessment, By Deliverables, 2021 & 2031F |
9.4 Canada Genomics Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Canada Genomics Market - Competitive Landscape |
10.1 Canada Genomics Market Revenue Share, By Companies, 2024 |
10.2 Canada Genomics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here